0.9% Cadexomer Iodine Gel and Pads
FAQ
Remove the secondary dressing. If it is sticking to the IODOSORB◊, soak with sterile saline or water. To remove IODOSORB◊ from the wound, simply flush it away with sterile saline or water. If there are any small remnants of IODOSORB◊ left in the wound, don't worry they will be naturally degraded without causing any delay to healing or systemic reaction.
Remove the secondary dressing. If it is sticking to the IODOSORB◊, soak with sterile saline or water. To remove IODOSORB◊ from the wound, simply flush it away with sterile saline or water. If there are any small remnants of IODOSORB◊ left in the wound, don't worry they will be naturally degraded without causing any delay to healing or systemic reaction.
IODOSORB◊ will change from a dark brown to off white which indicates that all the iodine has been released. This indicates that it is time to change the IODOSORB◊. The number of dressing changes therefore depend on the levels of infection and exudate present in the wound.
IODOSORB◊ will change from a dark brown to off white which indicates that all the iodine has been released. This indicates that it is time to change the IODOSORB◊. The number of dressing changes therefore depend on the levels of infection and exudate present in the wound.
Generally if you use IODOSORB◊ within the guidelines of the prescribing information (up to a maximum of 150g a week) it is unlikely that there will be any significant iodine absorption and therefore any systemic side effects. However, IODOSORB◊ should not be used in patients with severely impaired renal function or a past history of any thyroid disorder as they are more susceptible to alterations in thyroid metabolism with chronic IODOSORB◊ therapy. In endemic goitre there have been isolated reports of hyperthyroidism associated with exogenous iodine. It has been observed occasionally that an adherent crust can form when IODOSORB◊ is not changed with sufficient frequency.
Generally if you use IODOSORB◊ within the guidelines of the prescribing information (up to a maximum of 150g a week) it is unlikely that there will be any significant iodine absorption and therefore any systemic side effects. However, IODOSORB◊ should not be used in patients with severely impaired renal function or a past history of any thyroid disorder as they are more susceptible to alterations in thyroid metabolism with chronic IODOSORB◊ therapy. In endemic goitre there have been isolated reports of hyperthyroidism associated with exogenous iodine. It has been observed occasionally that an adherent crust can form when IODOSORB◊ is not changed with sufficient frequency.
Yes, you can use any semi-permeable secondary dressing, or secure IODOSORB◊ with bandages over a non-adherent piece of padding or gauze.
IODOSORB◊ desloughs by absorbing and drawing away slough and exudate from the wound surface. This is not harmful but indicates that the product is working. Sometimes patients feel a warm or smarting sensation and this may be due to the drawing effect of the slough and exudate.
IODOSORB◊ desloughs by absorbing and drawing away slough and exudate from the wound surface. This is not harmful but indicates that the product is working. Sometimes patients feel a warm or smarting sensation and this may be due to the drawing effect of the slough and exudate.
Yes, it has been shown to. Often IODOSORB◊ will relieve pain whilst in the process of desloughing the wound and killing bacteria. In clinical trials, pain reduction has been a well observed benefit for patients.
Because IODOSORB◊ contains elemental iodine, it is effective against a wide range of pathogenic bacteria, fungi, yeasts which can delay wound healing. Iodine is also highly effective against Methicillin Resistant Staphylococcus Aureus (MRSA). There have been no reports of acquired resistance with iodine.
Because IODOSORB◊ contains elemental iodine, it is effective against a wide range of pathogenic bacteria, fungi, yeasts which can delay wound healing. Iodine is also highly effective against Methicillin Resistant Staphylococcus Aureus (MRSA). There have been no reports of acquired resistance with iodine.
IODOSORB◊ can be used for up to 3 months. At this stage if the ulcer still needs treatment a non-iodine containing product must be used for a minimum of one week before resuming treatment with IODOSORB◊.
150g of IODOSORB◊ can be applied per patient per week. A single application should not exceed 50g. If more is needed, refer to the warnings on the relevant data sheet and prescribing information.
No, this is not recommended.
There is a body of evidence showing that some antiseptic containing products delay wound healing. IODOSORB◊ has been also tested in-vivo and has been shown not to reduce fibroblast or macrophage activity 18. IODOSORB◊ has in fact been shown to accelerate healing in some studies 2.
There is a body of evidence showing that some antiseptic containing products delay wound healing. IODOSORB◊ has been also tested in-vivo and has been shown not to reduce fibroblast or macrophage activity 18. IODOSORB◊ has in fact been shown to accelerate healing in some studies 2.